Marcus Crawford, MD
Plastic Surgery · Kennesaw, GANPI 1770787582
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (51.7%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Amgen at 44.1% of the total. Reporting peaked in 2021 at $2,319 and has fallen 73.3% since, to $620 in 2025.
Across 89 payments — averaging $72.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$3K
- Baxter Healthcare$2K
- Mentor Worldwide LLC$526
- Genentech USA, Inc.$281
- TG Therapeutics, Inc.$209
- AbbVie$182
- plus $741 from 19 others
What the payments were for
- Consulting fees$1,66526%
- Speaking & faculty fees$1,45523%
- Food & beverage$3,33352%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 27 | $2,849 |
| Baxter Healthcare | 2 | $1,665 |
| Mentor Worldwide LLC | 18 | $526 |
| Genentech USA, Inc. | 4 | $281 |
| TG Therapeutics, Inc. | 2 | $209 |
| AbbVie | 10 | $182 |
| Bard Peripheral Vascular, Inc. | 1 | $133 |
| Lundbeck LLC | 1 | $125 |
| Kowa Pharmaceuticals America, Inc. | 4 | $69 |
| Pacira Pharmaceuticals Incorporated | 2 | $65 |
| Integra Lifesciences Corporation | 4 | $64 |
| Polynovo North America LLC | 1 | $31 |
| Tepha Inc | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Kerecis Limited | 1 | $24 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $23 |
| Octapharma USA, Inc. | 1 | $20 |
| Apyx Medical Corporation | 1 | $20 |
| Davol Inc. | 1 | $19 |
| TELA Bio, Inc. | 1 | $19 |
| Acera Surgical, Inc. | 1 | $19 |
| KCI USA, Inc. | 1 | $18 |
| AstraZeneca | 1 | $16 |
| Eisai Inc. | 1 | $14 |
| Acelrx Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEPEZZA$1,920
- No Related Product$1,665
- OCREVUS$244
- MENTOR MemoryGel Resterilizable Gel Sizer$142
- VYEPTI$125
- KRYSTEXXA$122
- Ocrevus Zunovo$121
- BRIUMVI$110
How this compares
$6,453 in reported general payments places this provider in the 75th percentile of 163 plastic surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $142 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $29 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Kennesaw
- David ZabelAugusta$511K
- Albert LoskenAtlanta$436K
- Jonathan NguyenAtlanta$364K
- Brian MaloneyAtlanta$224K
- Michael McNeelMarietta$160K
- Farzad NahaiAtlanta$129K
- Michael KluskaCommerce$58K
- Sara NeimanisAtlanta$51K
- Alan LarsenAtlanta$48K
- Edmond RitterAugusta$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.